VRCA Stock Analysis: Buy, Sell, or Hold?
VRCA - Verrica Pharmaceuticals Inc. Common Stock
$5.25
0.03 (0.57%)
▲
5d:
-1.87%
30d:
-14.43%
90d:
-16.27%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
2d
Get Alerted When VRCA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VRCA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VRCA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VRCA is currently trading at $5.25, which is considered oversold relative to its 30-day fair value range of $5.32 to $6.29.
Technical Outlook: Technically, VRCA is showing sideways momentum. Immediate support is located at $5.00, while resistance sits at $5.87.
Market Sentiment: VRCA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.54 (+196.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VRCA is showing sideways momentum. Immediate support is located at $5.00, while resistance sits at $5.87.
Market Sentiment: VRCA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.54 (+196.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.32 -
$6.29
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 196.1% below Wall St target ($15.54)
Trading Range Analysis
30-Day Trading Range
$5.32 -
$6.29
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.00
Resistance Level
$5.87
Current Trend
Sideways
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.22
Wall Street Target
$15.54
(+196.1%)
Revenue Growth (YoY)
46.1%
Profit Margin
-48.0%
Share & Embed Analysis
Last updated: August 03, 2026 6:32 PM ET
Data refreshes hourly during market hours. Next update: 7:32 PM
Data refreshes hourly during market hours. Next update: 7:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VRCA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1080 | 57 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 59 HOLD |
